-
Something wrong with this record ?
Effects of adenosine A1 receptor antagonism on insulin secretion from rat pancreatic islets
A. Zywert, K. Szkudelska, T. Szkudelski
Language English Country Czech Republic
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Adenosine Triphosphate metabolism MeSH
- Cyclic AMP metabolism MeSH
- Adenosine A1 Receptor Antagonists pharmacology MeSH
- Insulin secretion MeSH
- Rats MeSH
- Islets of Langerhans metabolism drug effects MeSH
- Rats, Wistar MeSH
- Receptor, Adenosine A1 metabolism MeSH
- Xanthines pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
Adenosine is known to influence different kinds of cells, including β-cells of the pancreas. However, the role of this nucleoside in the regulation of insulin secretion is not fully elucidated. In the present study, the effects of adenosine A1 receptor antagonism on insulin secretion from isolated rat pancreatic islets were tested using DPCPX, a selective adenosine A1 receptor antagonist. It was demonstrated that pancreatic islets stimulated with 6.7 and 16.7 mM glucose and exposed to DPCPX released significantly more insulin compared with islets incubated with glucose alone. The insulin-secretory response to glucose and low forskolin appeared to be substantially potentiated by DPCPX, but DPCPX was ineffective in the presence of glucose and high forskolin. Moreover, DPCPX failed to change insulin secretion stimulated by the combination of glucose and dibutyryl-cAMP, a non-hydrolysable cAMP analogue. Studies on pancreatic islets also revealed that the potentiating effect of DPCPX on glucose-induced insulin secretion was attenuated by H-89, a selective inhibitor of protein kinase A. It was also demonstrated that formazan formation, reflecting metabolic activity of cells, was enhanced in islets exposed to DPCPX. Moreover, DPCPX was found to increase islet cAMP content, whereas ATP was not significantly changed. These results indicate that adenosine A1 receptor blockade in rat pancreatic islets potentiates insulin secretion induced by both physiological and supraphysiological glucose concentrations. This effect is proposed to be due to increased metabolic activity of cells and increased cAMP content.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12006338
- 003
- CZ-PrNML
- 005
- 20120906122746.0
- 007
- ta
- 008
- 120229s2011 xr d f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932165 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Zywert, A. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
- 245 10
- $a Effects of adenosine A1 receptor antagonism on insulin secretion from rat pancreatic islets / $c A. Zywert, K. Szkudelska, T. Szkudelski
- 504 __
- $a Literatura $b 26
- 520 9_
- $a Adenosine is known to influence different kinds of cells, including β-cells of the pancreas. However, the role of this nucleoside in the regulation of insulin secretion is not fully elucidated. In the present study, the effects of adenosine A1 receptor antagonism on insulin secretion from isolated rat pancreatic islets were tested using DPCPX, a selective adenosine A1 receptor antagonist. It was demonstrated that pancreatic islets stimulated with 6.7 and 16.7 mM glucose and exposed to DPCPX released significantly more insulin compared with islets incubated with glucose alone. The insulin-secretory response to glucose and low forskolin appeared to be substantially potentiated by DPCPX, but DPCPX was ineffective in the presence of glucose and high forskolin. Moreover, DPCPX failed to change insulin secretion stimulated by the combination of glucose and dibutyryl-cAMP, a non-hydrolysable cAMP analogue. Studies on pancreatic islets also revealed that the potentiating effect of DPCPX on glucose-induced insulin secretion was attenuated by H-89, a selective inhibitor of protein kinase A. It was also demonstrated that formazan formation, reflecting metabolic activity of cells, was enhanced in islets exposed to DPCPX. Moreover, DPCPX was found to increase islet cAMP content, whereas ATP was not significantly changed. These results indicate that adenosine A1 receptor blockade in rat pancreatic islets potentiates insulin secretion induced by both physiological and supraphysiological glucose concentrations. This effect is proposed to be due to increased metabolic activity of cells and increased cAMP content.
- 650 02
- $a antagonisté adenosinového receptoru A1 $x farmakologie $7 D058916
- 650 02
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a AMP cyklický $x metabolismus $7 D000242
- 650 02
- $a Dose-Response Relationship, Drug
- 650 02
- $a inzulin $x sekrece $7 D007328
- 650 02
- $a Langerhansovy ostrůvky $x metabolismus $x účinky léků $7 D007515
- 650 02
- $a krysa rodu Rattus $7 D051381
- 650 02
- $a potkani Wistar $7 D017208
- 650 02
- $a receptor adenosinový A1 $x metabolismus $7 D043682
- 650 02
- $a xanthiny $x farmakologie $7 D014970
- 700 1_
- $a Szkudelska, K. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
- 700 1_
- $a Szkudelsky, T. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
- 773 0_
- $t Physiological research $x 0862-8408 $g Roč. 60, č. 6 (2011), s. 905-911 $w MED00003824
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 2
- 990 __
- $a 20120229072848 $b ABA008
- 991 __
- $a 20120906122917 $b ABA008
- 999 __
- $a ok $b bmc $g 899391 $s 763166
- BAS __
- $a 3
- BMC __
- $a 2011 $b 60 $c 6 $d 905-911 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $a 2012-12/ipme